February 6, 2019
Updated 2mo ago
Alimera Sciences is a company focuses on diseases impacted the retina (back of the eye). Diabetic Macular Edema, DME, is a disease that can cause blindness in diabetic patients. Alimera has received FDA approval of their eye implant that treats DME: a product called Iluvien. Rick Eiswirth, President and CEO, discusses the Iluvien injection and how the treatment is different from what's on the market.